The Kaplan–Meier survival analysis confirmed that p16-positive UCA cases had better OS, reinforcing p16’s value as both a diagnostic and prognostic marker in HPV-associated adenocarcinomas [51,52]. The gene discussed is CDKN2A; the disease is adenocarcinoma.